Innovent and HUTCHMED received conditional approval for the combo in endometrial cancer from China’s NMPA last year.

Immunovant will use results from its Phase III myasthenia gravis study to support pipeline candidate IMVT-1402 over the trial ...

Immunovant and Roivant Sciences said Wednesday their rare disease drug succeeded in a final-phase study, but the duo won't seek approval.

Immunovant's batoclimab showed positive Phase 3 results in MG but won't be pursued for approval as the company shifts focus ...

OpenAI and Google claim that restricting AI model training on copyrighted data would give China a competitive edge in AI development.

Hudson's Bay is set to be back in court on Monday morning, where it will seek approval to begin liquidating its entire ...

Film and drama producers planning to create content with religious themes or involving uniformed services have been advised ...

Results showed Orca’s treatment, a purified mix of donor-derived T cells and stem cells, was safer than standard transplant ...

Hornby is seeking shareholder approval to cancel trading of its shares on London's junior AIM, saying it believes re-registering as a private company would better allow it to continue its ...

Newport News-based Westwood LLC wants to rezone roughly 80 acres in order to build 186 residential units and 40,000 square feet of commercial space. Texas-based D.R. Horton Homes is pursuing a ...